IRIS
CACCIOLA, Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.566
AS - Asia 7.208
EU - Europa 6.589
SA - Sud America 1.295
AF - Africa 473
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 29.152
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.969
SG - Singapore 4.048
RU - Federazione Russa 1.834
CN - Cina 1.791
IE - Irlanda 1.328
UA - Ucraina 1.264
BR - Brasile 1.069
IT - Italia 777
VN - Vietnam 523
CA - Canada 500
FR - Francia 449
KR - Corea 211
DE - Germania 200
NG - Nigeria 187
GB - Regno Unito 173
IN - India 159
SE - Svezia 140
CI - Costa d'Avorio 107
AR - Argentina 75
NL - Olanda 71
PL - Polonia 67
BD - Bangladesh 61
CH - Svizzera 57
MX - Messico 56
ZA - Sudafrica 52
TR - Turchia 47
UZ - Uzbekistan 47
IQ - Iraq 44
EC - Ecuador 41
FI - Finlandia 41
JP - Giappone 39
ES - Italia 35
HK - Hong Kong 29
KE - Kenya 29
ID - Indonesia 28
PK - Pakistan 28
CO - Colombia 26
VE - Venezuela 25
AT - Austria 21
SA - Arabia Saudita 21
GR - Grecia 19
EG - Egitto 18
MA - Marocco 18
LB - Libano 17
SN - Senegal 17
CZ - Repubblica Ceca 16
BE - Belgio 14
BJ - Benin 14
PY - Paraguay 14
CL - Cile 13
PE - Perù 13
RO - Romania 13
LT - Lituania 12
TW - Taiwan 12
BG - Bulgaria 11
PH - Filippine 11
IL - Israele 9
JO - Giordania 9
MY - Malesia 9
PT - Portogallo 9
UY - Uruguay 9
BY - Bielorussia 8
EU - Europa 8
IR - Iran 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
BO - Bolivia 7
DZ - Algeria 7
NP - Nepal 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
KW - Kuwait 6
KZ - Kazakistan 6
LY - Libia 6
AZ - Azerbaigian 5
ET - Etiopia 5
PS - Palestinian Territory 5
HR - Croazia 4
NI - Nicaragua 4
OM - Oman 4
SI - Slovenia 4
AL - Albania 3
AM - Armenia 3
CR - Costa Rica 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BH - Bahrain 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
PA - Panama 2
Totale 29.127
Salva come PNG Salva come JPEG
Città #
Dallas 2.533
Singapore 2.231
Dublin 1.324
Jacksonville 1.218
Santa Clara 1.174
Ashburn 1.049
Chandler 954
San Jose 795
Moscow 683
Boardman 526
Nanjing 422
Andover 367
Cambridge 360
Toronto 356
Lawrence 353
Lauterbourg 348
Hefei 247
San Mateo 229
Seoul 210
Des Moines 202
Chicago 196
Los Angeles 184
Ho Chi Minh City 156
Beijing 150
Catania 144
Wilmington 144
Nanchang 123
Hanoi 113
Abidjan 107
Lagos 103
São Paulo 100
Hebei 98
Shenyang 95
Saint Petersburg 84
New York 82
Council Bluffs 79
Grafing 77
Ottawa 77
Jiaxing 75
Civitanova Marche 73
Buffalo 72
Changsha 68
Abuja 66
Tianjin 66
Warsaw 53
Montreal 39
Rio de Janeiro 39
Bari 34
Milan 33
Phoenix 33
Tokyo 33
Orem 32
Amsterdam 31
Dong Ket 30
Johannesburg 30
Seattle 30
Brooklyn 29
Bremen 28
Boston 27
Da Nang 27
Washington 27
Denver 26
Palermo 26
Kunming 25
Norwalk 25
Poplar 25
Pune 25
Redondo Beach 25
Hong Kong 24
Munich 24
Quito 24
San Francisco 24
Atlanta 23
Houston 23
Stockholm 23
Tashkent 23
Den Haag 22
Chennai 21
Helsinki 21
Belo Horizonte 20
London 20
Mumbai 20
Curitiba 19
Hangzhou 19
Liberty Lake 19
Manchester 19
Ann Arbor 18
Baghdad 18
Brasília 18
Haiphong 18
Port Harcourt 18
Dakar 17
Mexico City 16
Augusta 14
Brussels 14
Cotonou 14
Jinan 14
Ningbo 14
Porto Alegre 14
The Dalles 14
Totale 19.454
Salva come PNG Salva come JPEG
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 464
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 208
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 204
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 190
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis. 184
B-linfociti CALLA (CD10) positivi nella leucemia linfatica cronica. 181
Activation of coaugulation and fibrinolysis in laparoscopic surgery 167
Thrombotic risk stratification in patients with prefibrotic myelofibrosis 166
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 157
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 152
A rare case of myeloid sarcoma presenting as anal fissure. 149
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 146
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 145
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 143
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 142
Abnormal Erytropoietin serum levels in acute leukemia could have a role in the pathophysiology of disease. 142
Activation coagulation and fibrinolysis in laparoscopic surgery 142
Activation of coagulation anf fibrinolysis in laparoscopic surgery 142
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 142
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 138
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 135
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 134
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 133
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untrated patients with chronic lymphocytic leukemia. 132
Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings. 130
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 128
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 127
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 125
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 123
Phase II randomized clinical trial comparing ropeginterferon versus phlebotomy in low-risk patients with polycythemia vera. Results of the pre-planned interim analysis. 122
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 120
Is it Still Reasonable to Raise Doubts on Laparoscopic Splenectomy? 120
Acute lymphoblastic leukemia in elderly. 119
Idiopathic intramural hematoma of the right colon. A case report and review of the literature. 119
Acquired antithrombin III deficency in sickle cell disease/beta plus thalas- semia. 118
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 117
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 117
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 117
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 117
How to prevent intraoperative risks and complications in laparoscopic splenectomy 116
Alteration of endothelium-coagulative system during COPD exacerbations 116
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 115
"In vitro" hyperresponsivity of diabetic platelets to "saturated" platelet-activating factor (PAF). 113
Laparoscopic splenectomy: a single center experience 112
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 108
Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms 108
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 107
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 105
Long-term results after splenectomy in adult idiopathic thrombocitopenic purpura: comparison between open and laparoscopic procedures 104
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 104
Cessazione del fumo di sigaretta e riduzione dei livelli plasmatici di fattore di von Willebrand (vWF) 104
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS. 103
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 101
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 100
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 99
In vitro sensitivity of B-CLL cells to Fludarabine and Interferons 99
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 99
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 99
Retroperitoneal paraduodenal unicentric Castleman disease: case report and review of the literature 98
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 98
The use of surgical drains in laparoscopic splenectomies. Consideration on a large series of 117 consecutive cases 98
Low dose of ARA-C in chronic myeloid leukemia in blastic transformation 97
I disordini dell'emostasi nelle emopatie maligne. 96
The Antiphospholipid Syndrome 96
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 96
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 95
Aspirin-platelet sensotivity in patients with essentila thtombocythemia: role of betafibrinogen G-455-A gene polymorphism 95
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 94
T-subset abnormalities in Thalassemia intermedia: Possible evidence for a Thymus functional deficiency. 93
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 93
Alpha interferon as a first line therapy for angioimmunoblastic lympho- adenopathy. Possible value of DR+ cells in monitoring therapeutical re- sponse. 92
Immunomodulating treatment in patients with aplastic anemia. 91
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 91
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 91
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 90
All-trans retinoic acid might also induce apoptosis in freshly isolated chro- nic myeloid leukemia cells 90
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 90
Unusual onset of severe varicella in adult immunocompromised patients 89
Factor-VIII-rela- ted antigen and vasculitis. 89
Il mitoxantrone in polichemioterapia associato allo schema CVP nel trat- tamento dei linfomi non hodgkin. 89
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 88
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 88
Effects of anagrelide on platelet and fibrinolytic function in patients with essential thrombocythemia 88
B- chronic lymphocytic lekemia cells forming rosettes with sheep erythrocytes 88
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 87
The antiphospholipid syndrome in pregnancy: a review article 87
MECCANISMO DI ATTIVAZIONE PIASTRINICA NELLA TROMBOCITEMIA ESSENZIALE: RUOLO DEGLI ANTICORPI ANTI CELLULA ENDOTELIALE (AACE) 86
Le anemie carenziali. 86
Low-dose cytarabine in myelodisplastic syndromes and acute leukemia: a comment 86
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 86
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 86
Laparoscopic splenectomy reduces the need of platelet transfusion in patients operated on for idiopathic thrombocytopenic purpura 86
Cutaneous vasculitis in non Hodgkin's Lymphoma. 85
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis 85
Thymostimulin in aplastic anaemia. 85
COVID-19 in Essential Thrombocythemia: Coagulopathy and Thrombosis 85
Trattamento preoperatorio con interleuchina-2 nel carcinoma colorettale. 83
Interleukin-8 levels in patients with essential thrombocythemia. 83
Prothrombin concentration in patients heterozygous for the G20210 and Arg506Gln mutations 83
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta Thalassemia: a pilot study. 82
Totale 11.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 0 0 0 0 10 163 61
2021/20222.657 346 387 21 30 429 5 394 92 282 5 63 603
2022/20233.474 365 93 28 229 348 652 4 576 971 29 115 64
2023/20241.666 81 110 73 86 65 160 160 355 17 40 230 289
2024/20255.265 38 716 369 170 1.183 404 110 201 517 689 313 555
2025/202612.017 704 595 2.641 779 2.097 2.043 1.838 295 661 364 0 0
Totale 29.638